本文へスキップ

相互作用

Cyclosporine + Liposomal doxorubicin

重症度: 重大

Cyclosporine and Liposomal doxorubicin: major interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Cyclosporine inhibits P-glycoprotein and CYP3A4 and has been reported to increase doxorubicin exposure and toxicity, including myelosuppression. Cases of severe neutropenia and neurotoxicity have been reported with the combination of anthracyclines and cyclosporine. Additive immunosuppression further raises infection risk.

この相互作用をわかりやすく説明すると

Cyclosporine and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

エビデンスレベル: Moderate

なぜ起こるのか

Cyclosporine inhibits P-gp and CYP3A4, reducing doxorubicin clearance, with additive immunosuppression.

対処法

Monitor blood counts, cardiac function and signs of infection closely, and consider reducing the doxorubicin dose. Avoid the combination when alternatives exist.

薬剤師に尋ねること

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、CyclosporineとLiposomal doxorubicinの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を14日間無料でお試し。カード登録不要。

よくある質問

Can I take Cyclosporine with Liposomal doxorubicin?

MediHelp rates the interaction as major. Cyclosporine and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Cyclosporine inhibits P-glycoprotein and CYP3A4 and has been reported to increase doxorubicin exposure and toxicity, including myelosuppression. Cases of severe neutropenia and neurotoxicity have been reported with the combination of anthracyclines and cyclosporine. Additive immunosuppression further raises infection risk.

How serious is the interaction between Cyclosporine and Liposomal doxorubicin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts, cardiac function and signs of infection closely, and consider reducing the doxorubicin dose. Avoid the combination when alternatives exist.

What other medicines interact with Liposomal doxorubicin?

MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Belatacept, Dronedarone. The full list is on the Liposomal doxorubicin page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン